Investment Announcement! – SciTech

Media Alert – Investment Announcement!

August 10th 2023 – Birmingham, Michigan – CitySide Ventures and GLAF announce adding SciTech to its portfolio of companies.

CitySide Ventures Grate Lakes Angels Fund participated in the companys’ $2.5M Seed round. 

SciTech is a clinical stage, biopharmaceutical company that has developed a proprietary nano-delivery system (SciTech Drug Delivery Platform – SDP) to enable intravenous (IV) delivery of water-insoluble drugs. One such challenged drug or active pharmaceutical ingredient (API) is fenretinide, the API in SciTech’s lead drug candidate, has been shown in numerous clinical trials to be a relatively safe and effective anticancer therapy with targeted cancer destroying activity. The patented combination of the new SDP and fenretinide has led to SciTech’s first drug candidate, ST-001 nanoFenretinide, that holds the promise of improving and saving many lives.

“We are pleased that they have not only had a production run and it met FDA requirements, the drug is safe, UPMC has signed on as the 1st clinical test site – these are some of the de-risking they have achieved thus far.  Looks very promising!   ”– David Weaver – President Emeritus, CitySide Ventures 

CitySide Ventures is to become a premier Investment group committed to taking Michigan Angel investing to a new level by building a network of active, progressive, and innovative investors committed to turning Michigan into a powerhouse startup ecosystem.

For more information about Birmingham Angels please visit us at http://citysideventures.com/birmingham-angels/

For more information about Great Lakes Angels Fund please visit us at http://citysideventures.com/glaf/

If you are an accredited investor and would like to schedule a private meeting,

please complete the following request form: http://citysideventures.com/birmingham-angels-individual/

or contact us: dweaver@citysideventures.com or 248. 535.1306

******************